What is the Impact Factor of Human Gene Therapy Methods?

The journal Human Gene Therapy Methods is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Human Gene Therapy Methods indexed in Web of Science or Scopus?

Yes, Human Gene Therapy Methods is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q1) and an H-index of 20.

Who publishes Human Gene Therapy Methods and what is the Article Processing Charge (APC)?

Human Gene Therapy Methods is published by Mary Ann Liebert Inc.. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

What is the ISO-4 abbreviation and acronym of Human Gene Therapy Methods?

The official ISO-4 abbreviation of Human Gene Therapy Methods is "Hum. Gene Ther. Methods" with common acronym "hum". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Hybrid

Human Gene Therapy Methods

Acronym:hum

•

Abbreviation (ISO):Hum. Gene Ther. Methods

•

Identifier (ISSN):1946-6536(Print)/1946-6544(Online)

•

Publisher:Mary Ann Liebert Inc.

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2018–2023)

Clarivate IF trend for Human Gene Therapy Methods

WoS Q1

Annual Impact Factor Metric

Current (2023):0

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (2021)

20 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

27articles/year

12.5% Gold OA•0% Original Research

Aims & Scope

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases. The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

Topics Covered (Recognized by AI)

Biology99.6%Genetics98.2%Chemistry96%Biochemistry95.6%Gene89.7%Medicine81.3%Recombinant DNA62.1%Immunology51.1%Virology46.7%Internal medicine46%Genetic enhancement46%Cell culture43.8%Molecular biology43.8%Vector (molecular biology)39.3%Viral vector36%Cell biology32.4%Virus32%Transfection31.6%Computational biology27.9%Adeno-associated virus25.7%Botany24.3%Gene delivery23.2%Biophysics22.1%Transduction (biophysics)21%DNA20.6%

Primary Research Areas

Biotechnology & Applied Microbiology Genetics & Heredity

Official Website NLM PubMed Catalog Submission Portal

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year

2023Latest

IF0

Articles / Year—

Total Citations—

2021

IF2.396

Articles / Year—

Total Citations—

2020

IF2.446

Articles / Year—

Total Citations—

2019

IF2.089

Articles / Year27

Total Citations702

2018

IF2.3

Articles / Year23

Total Citations394

Year	Impact Factor	Articles / Year	Total Citations
2023	0	—	—
2021	2.396	—	—
2020	2.446	—	—
2019	2.089	27	702
2018	2.3	23	394
2017	—	40	1,296
2016	—	24	637
2015	—	27	952
2014	—	31	522
2013	—	52	1,797
2012	—	48	1,797

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Human Gene Therapy Methods (acronym: hum, abbr: Hum. Gene Ther. Methods, ISSN: 1946-6536) is a peer-reviewed international scholarly journal in the field of BIOTECHNOLOGY & APPLIED MICROBIOLOGY, published by Mary Ann Liebert Inc. in United States. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 20.

The journal enforces rigorous peer evaluation with an annual output of approximately 27 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.